We are direct about the limits of the evidence
Trier JS, Szabo S, Allan CH
34,35 However, the controversy surrounding the possible benefits of GIPR agonism stems from two main observations: its impaired insulinotropic effects, 36,37 and the prevention of weight gain by suppression of endogenous GIP-induced adipogenesis, 38,39 However, these seemingly discouraging observations have been questioned by the finding of the central anorexic effects of GIP, 4042 and benefits of the GLP-1R/GIPR dual agonist LY3298176 (tirzepatide) in diabetic and overweight individuals
When researchers isolated and studied it, they discovered something remarkable: exogenous BPC-157 (injected or supplemented) dramatically accelerates the repair process far beyond what your natural levels alone can achieve
Inositol phosphates and cell signalling